Supernus Pharmaceuticals Overview

Supernus Pharmaceuticals Profit Margin

Profitability ratio analysis for SUPN.

Quarterly Profit Margin

-1.10%

↑ 86.01% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-0.02%

↓ 100.16% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin